FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2586756870> ?p ?o ?g. }

• W2586756870 abstract "Abstract Abstract 985 Despite advances in clinical care, multiple myeloma (MM) remains an almost universally fatal disease. Velcade, a novel proteasome inhibitor represents a promising new clinical strategy for relapsed and refractory MM. However, only 30–40% of MM patients respond to this treatment. In order to gain insight into the mechanism of velcade resistance, we examined the differentially expressed proteins between 8226S (velcade sensitive) and 8226R5 (velcade resistant) myeloma cell lines using iTRAQ mass spectrometry (MS). The MS based multiple-reaction-monitoring technique (MRM) was then used to independently verify the quantitative differences of the protein expression levels between the two cell lines. We identified several cancer specific proteins to be highly differentially expressed between 8226S and 8226R5 by iTRAQ mass spectrometry. Of particular interest is Myristoylated Alanine-Rich C-Kinase Substrate (MARCKS), a PKC substrate that has been implicated in conferring drug resistance to ovarian carcinoma cells. Differential expression of MARCKS between sensitive and resistant cells was verified by MRM and then confirmed by RT-PCR and Western blot analysis. MARCKS over-expression was also found in additional MM cell lines as well as patient samples that were resistant to velcade. Knockdown of MARCKS through siRNA strategies enhanced velcade sensitivity by increasing apoptosis in the velcade treated resistant cell line 8226R5. Moreover, inhibition of PKC, the upstream activator of MARCKS by enzastaurin significantly blocked phosphorylation of MARCKS leading to a caspase dependent apoptosis in the 8226R5 cells. In addition, enzastaurin enhanced velcade proteosome inhibitory effect and rendered the 8226R5 cells more sensitive to velcade treatment. Combination of velcade with enzastaurin showed a synergistic cytotoxic response in MM cells compared to either drug used alone. Furthermore, knockdown of MARCKS or inhibition of MARCKS phosphorylation by enzastaurin led to a decrease in Skp2 expression and an increase in p27 and p21, as well as a reduction of cyclin E and CDK2, resulting in G1/S cell cycle arrest and an increase in apoptosis in MM cells. Taken together our results suggest that phosphorylated MARCKS plays an important role in velcade resistance in MM and as such may be used as an important therapeutic target. In addition, MARCKS may be a biomarker to select patients that would most benefit from patient specific treatment. Disclosures: No relevant conflicts of interest to declare." @default.
• W2586756870 created "2017-02-17" @default.
• W2586756870 creator A5018664175 @default.
• W2586756870 creator A5028343495 @default.
• W2586756870 creator A5084433596 @default.
• W2586756870 date "2011-11-18" @default.
• W2586756870 modified "2023-09-30" @default.
• W2586756870 title "MARCKS Confers Resistance to Velcade Through Skp2/p27-Mediated Pathway in Multiple Myeloma" @default.
• W2586756870 doi "https://doi.org/10.1182/blood.v118.21.985.985" @default.
• W2586756870 hasPublicationYear "2011" @default.
• W2586756870 type Work @default.
• W2586756870 sameAs 2586756870 @default.
• W2586756870 citedByCount "0" @default.
• W2586756870 crossrefType "journal-article" @default.
• W2586756870 hasAuthorship W2586756870A5018664175 @default.
• W2586756870 hasAuthorship W2586756870A5028343495 @default.
• W2586756870 hasAuthorship W2586756870A5084433596 @default.
• W2586756870 hasConcept C114851261 @default.
• W2586756870 hasConcept C184235292 @default.
• W2586756870 hasConcept C185592680 @default.
• W2586756870 hasConcept C190283241 @default.
• W2586756870 hasConcept C195794163 @default.
• W2586756870 hasConcept C27740335 @default.
• W2586756870 hasConcept C2780780085 @default.
• W2586756870 hasConcept C502942594 @default.
• W2586756870 hasConcept C54355233 @default.
• W2586756870 hasConcept C55493867 @default.
• W2586756870 hasConcept C71924100 @default.
• W2586756870 hasConcept C81885089 @default.
• W2586756870 hasConcept C86803240 @default.
• W2586756870 hasConcept C89423630 @default.
• W2586756870 hasConceptScore W2586756870C114851261 @default.
• W2586756870 hasConceptScore W2586756870C184235292 @default.
• W2586756870 hasConceptScore W2586756870C185592680 @default.
• W2586756870 hasConceptScore W2586756870C190283241 @default.
• W2586756870 hasConceptScore W2586756870C195794163 @default.
• W2586756870 hasConceptScore W2586756870C27740335 @default.
• W2586756870 hasConceptScore W2586756870C2780780085 @default.
• W2586756870 hasConceptScore W2586756870C502942594 @default.
• W2586756870 hasConceptScore W2586756870C54355233 @default.
• W2586756870 hasConceptScore W2586756870C55493867 @default.
• W2586756870 hasConceptScore W2586756870C71924100 @default.
• W2586756870 hasConceptScore W2586756870C81885089 @default.
• W2586756870 hasConceptScore W2586756870C86803240 @default.
• W2586756870 hasConceptScore W2586756870C89423630 @default.
• W2586756870 hasLocation W25867568701 @default.
• W2586756870 hasOpenAccess W2586756870 @default.
• W2586756870 hasPrimaryLocation W25867568701 @default.
• W2586756870 hasRelatedWork W1967351582 @default.
• W2586756870 hasRelatedWork W1993818695 @default.
• W2586756870 hasRelatedWork W2011488536 @default.
• W2586756870 hasRelatedWork W2050958378 @default.
• W2586756870 hasRelatedWork W2055525267 @default.
• W2586756870 hasRelatedWork W2411795098 @default.
• W2586756870 hasRelatedWork W2530979006 @default.
• W2586756870 hasRelatedWork W2556179041 @default.
• W2586756870 hasRelatedWork W2557392219 @default.
• W2586756870 hasRelatedWork W2560139420 @default.
• W2586756870 hasRelatedWork W2561245808 @default.
• W2586756870 hasRelatedWork W2565391088 @default.
• W2586756870 hasRelatedWork W2566683404 @default.
• W2586756870 hasRelatedWork W2568747459 @default.
• W2586756870 hasRelatedWork W2590261155 @default.
• W2586756870 hasRelatedWork W2595210719 @default.
• W2586756870 hasRelatedWork W2964527614 @default.
• W2586756870 hasRelatedWork W2979732157 @default.
• W2586756870 hasRelatedWork W3016497539 @default.
• W2586756870 hasRelatedWork W3191097563 @default.
• W2586756870 isParatext "false" @default.
• W2586756870 isRetracted "false" @default.
• W2586756870 magId "2586756870" @default.
• W2586756870 workType "article" @default.